Verschiedene ^99mTc-Generatoreluate: Auswirkungen auf die radiochemische Reinheit der Markierungsprodukte = Different ^99mTc-generator eluates: consequences on the radiochemical purity of the labelling productsSCHOMÄCKER, K; GERAD, H; GABRUK-SZOSTAK, B et al.Nuclear-Medizin. 1994, Vol 33, Num 1, pp 33-39, issn 0029-5566Article

Cerebral perfusion changes in schizophrenic patients using Tc-99m hexamethylpropylene amineoxime (HMPAO)ABDEL-DAYEM, H. M; EL-HILU, S; SEHWEIL, A et al.Clinical nuclear medicine. 1990, Vol 15, Num 7, pp 468-472, issn 0363-9762Article

The biodistribution of technetium-99m-hexamethylpropylene amine oximeWEI-JEN SHIH; COUPAL, J; MAGOUN, S et al.Seminars in nuclear medicine. 1994, Vol 24, Num 2, pp 180-183, issn 0001-2998Article

The diagnosis of brain death with Tc-99m HMPAOWILSON, K; GORDON, L; SELBY, J. B et al.Clinical nuclear medicine. 1993, Vol 18, Num 5, pp 428-434, issn 0363-9762Article

¹²³J-Iomazenil- und ^99mTc-HMPAO in der Diagnostik fokaler Epilepsien: Vergleich von unbehandelten und behandelten Patienten = ¹²³I-Iomazenil and ⁹⁹³Tc-HMPAO in the diagnosis of focal epilepsies: comparison of treated und untreated patientsVENZ, S; CORDES, M; SCHMITZ, B et al.Nuclear-Medizin. 1994, Vol 33, Num 1, pp 1-7, issn 0029-5566Article

Quantification of technetium-99m hexamethylpropylene amine oxime brain uptake in routine clinical practice using calibrated point sources as an external standard : phantom and human studiesDOBBELEIR, A; DIERCKX, R.European journal of nuclear medicine. 1993, Vol 20, Num 8, pp 684-689, issn 0340-6997Article

Tumour-like thallium-201 accumulation in brain infarcts, an unexpected finding on single-photon emission tomographyBERNAT, I; TOTH, G; KOVACS, L et al.European journal of nuclear medicine. 1994, Vol 21, Num 3, pp 191-195, issn 0340-6997Article

Brain SPET and auditory cortex perfusion. Technical notes and preliminary resultsDE ROSSI, G; GIORDANO, A; CALCAGNI, M. L et al.Nuclear medicine communications. 1994, Vol 15, Num 7, pp 565-568, issn 0143-3636Article

Radiochemical purity testing for ⁹⁹Tc^m-exametazime: a comparison study for three-paper chromatographyHUNG, J. C; TAGGART, T. R; WILSON, M. E et al.Nuclear medicine communications. 1994, Vol 15, Num 7, pp 569-574, issn 0143-3636Article

Crossed cerebello-cerebral diaschisis : a SPECT studyBONI, S; VALLE, G; CIOFFI, R. P et al.Nuclear medicine communications. 1992, Vol 13, Num 11, pp 824-831, issn 0143-3636Article

Parameters influencing SPET regional brain uptake of technetium-99m hexamethylpropylene amine oxime measured by calibrated point sources as an external standardDIERCKX, R. A; DOBBELEIR, A; MAES, M et al.European journal of nuclear medicine. 1994, Vol 21, Num 6, pp 514-520, issn 0340-6997Article

¹⁸FDG PET and acetazolamide-enhanced ^99mTc-HMPAO SPET in systemic lupus erythematosusGRÜNWALD, F; SCHOMBURG, A; ACHIM BADALI et al.European journal of nuclear medicine. 1995, Vol 22, Num 9, pp 1073-1077, issn 0340-6997Article

Detection of bilateral and symmetrical anomalies in technetium-99m-HMPAO brain SPECT studiesDENAYS, R; HAM, H; TONDEUR, M et al.JNM : (1990). 1992, Vol 33, Num 4, pp 485-490Article

⁹⁹Tc^m-HMPAO-labelled leucocytes for bone marrow scintigraphy and evaluation of skeletal lesions. Comparison with ⁹⁹Tc^m-HSA colloid resultsBOURGEOIS, P; DEMONCEAU, G; STEGEN, M et al.Nuclear medicine communications. 1991, Vol 12, Num 7, pp 621-627, issn 0143-3636Article

Luxury perfusion with ^99mTc-HMPAO and ¹²³I-IMP SPECT imaging during the subacute phase of strokeMORETTI, J.-L; DEFER, G; CINOTTI, L et al.European journal of nuclear medicine. 1990, Vol 16, Num 1, pp 17-22, issn 0340-6997Article

Traitement de l'hydrocépahile par l'acétazolamide. Evaluation par la tomoscintigraphie au technétium 99m hexaméthylpropylène amine oxime = Treatment of hydrocephalus with acetozolamide. Evaluation by 99m Tc-HMPAO brain SPECTMORETTI, J. L; BAILLET, G; TAMGAC, F et al.Médecine nucléaire (Paris). 1994, Vol 18, Num 2, pp 59-61, issn 0928-1258Article

A comparative study of ⁹⁹Tc^m-HMPAO and ⁹⁹Tc^m-ECD as a laukocyte labelling agentKAO, C. H; HUANG, W. T; WANG, Y. L et al.Nuclear medicine communications. 1994, Vol 15, Num 4, pp 294-297, issn 0143-3636Conference Paper

Changes of Tc-99m HMPAO brain distribution in herpes encephalitisLE SCAO, Y; TURZO, A; GUIAS, M et al.Clinical nuclear medicine. 1993, Vol 18, Num 5, pp 452-453, issn 0363-9762Article

Regional cerebral blood flow in Angelman syndromeGÜCÜYENER, K; GÖKCORA, N; ILGIN, N et al.European journal of nuclear medicine. 1993, Vol 20, Num 7, pp 645-647, issn 0340-6997Article

Intrasubject comparison between technetium-99m-ECD and technetium-99m-HMPAO in healthy human subjectsLEVEILLE, J; DEMONCEAU, G; WALOVITCH, R. C et al.JNM : (1990). 1992, Vol 33, Num 4, pp 480-484Article

⁹⁹Tc^m-HMPAO brain SPECT in the evaluation of prognosis after surgical resection of astrocytoma. Comparison with other noninvasive imaging techniques (CT, MRI and ^20&T1 SPECT)RODRIGUES, M; FONSECA, A. T; SALGADO, D et al.Nuclear medicine communications. 1993, Vol 14, Num 12, pp 1050-1060, issn 0143-3636Article

Drug effects on cerebral blood flow in the baboon model: acetazolamine and nimodipineOLIVER, D. W; DORMEHL, I. C; REDELINGHUYS, I. F et al.Nuclear-Medizin. 1993, Vol 32, Num 6, pp 292-298, issn 0029-5566Article

Elution analysis and normal biodistribution of Technetium-99m HMPAO-labeled white blood cellsKAO, C. H; WANG, Y. L; WANG, S. J et al.Journal of nuclear medicine technology. 1992, Vol 20, Num 4, pp 224-227, issn 0091-4916Article

High spatial resolution Tc-99m HMPAO brain SPECT in cerebellar embolic infarctionDIERCKX, R; FIDLERS, L; DOBBELEIR, A et al.Clinical nuclear medicine. 1993, Vol 18, Num 1, pp 83-84, issn 0363-9762Article

Quantitative single-photon emission tomography for tumor blood flow measurement in bronchial carcinomaROWELL, N. P; FLOWER, M. A; CRONIN, B et al.European journal of nuclear medicine. 1993, Vol 20, Num 7, pp 591-599, issn 0340-6997Article